Using strategic price negotiations to contain costs and expand access to medicines in China

被引：26

作者：

Si, Lei ^{[1
,2
]}

Xu, Lizheng ^{[3
]}

Chen, Mingsheng ^{[4
,5
,6
]}

Jan, Stephen ^{[1
,2
]}

机构：

[1] UNSW Sydney, George Inst Global Hlth, Sydney, NSW, Australia

[2] UNSW Sydney, UNSW Med, Sydney, NSW, Australia

[3] Shandong Univ, Sch Publ Hlth, Jinan, Peoples R China

[4] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Peoples R China

[5] Nanjing Med Univ, Creat Hlth Policy Res Grp, Nanjing, Peoples R China

[6] Nanjing Med Univ, Ctr Global Hlth, Nanjing, Peoples R China

来源：

BMJ GLOBAL HEALTH | 2020年 / 5卷 / 01期

基金：

英国医学研究理事会; 中国国家自然科学基金;

关键词：

health policy; health economics;

D O I：

10.1136/bmjgh-2019-002256

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页数：2

共 7 条

[1]

BNF, BNF FORM

[2]

Chian Naitonal health accounts report, 2018, CHIAN NAIT HLTH ACC

[3] Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts [J].

Hu, Jia ;

Mossialos, Elias .

HEALTH POLICY, 2016, 120 (05) :519-534

[4] Containing medical expenditure: lessons from reform of Beijing public hospitals [J].

Liu, Xiaoyun ;

Xu, Jin ;

Yuan, Beibei ;

Ma, Xiaochen ;

Fang, Hai ;

Meng, Qingyue .

BMJ-BRITISH MEDICAL JOURNAL, 2019, 365

[5]

MENG QY, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2349

[6]

NHSA, 2019, NOT INCL YEAR 2019 N

[7]

Richards T, 2018, CHINA SET BAR HIGH N

← 1 →